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Abstract
Lymphangioleiomyomatosis is a rare disorder of unknown origin that usually presents pulmonary
symptoms. Retroperitoneal lymphangioleiomyomatosis without lung involvement has rarely been
reported. We present a 38-year-old woman, the fourth case reported of retroperitoneal
lymphangioleiomyomatosis with endosalpingiosis in the literature.
Introduction
Lymphangioleiomyomatosis (LAM) is a rare disorder of
unknown origin that almost exclusively affects women of
childbearing age [1,2]. It is characterized by the formation
of thin-walled cysts and hamartomatous proliferation of
immature smooth muscle cells of the lymph nodes,
lymphatics, blood vessels, alveoli, mediastinum, and
retroperitoneum [2].
Pulmonary LAM is the most common form of occurrence
of this disorder. Occasionally, pulmonary LAM is
presented with extrapulmonary symptoms characterized
by retroperitoneal lympadenopathy, chylous ascites, and
renal angiomyolipomas (AML) [2,3]. However, extra-
pulmonary LAM without lung involvement has rarely
been reported. In this study, we present the fourth case of
retroperitoneal LAM with endosalpingiosis reported in the
literature.
Case presentation
A 38-year-old white woman with a history of oral contra-
ceptive use, presented with a non-quantified weight loss over
a 9-month period with no further clinical complaints.
Furthermore, laboratory data showed no abnormalities.
Computed tomography (CT) studies of the abdomen
demonstrated a 10-cm cystic mass in the retroperitoneum,
surroundingtheaorta,onthe medialside ofthe inferiorvena
cava bordering the superior and inferior mesenteric arteries,
the left renal hilum, pancreatic body, and left psoas muscle
(Figure 1). Under radiological suspicion of retroperitoneal
lymphangioma, the decision was made to excise the cystic
mass as well as the periaortic and retroperitoneal lymphade-
nopathy(Figure2).Thepostoperativeperiodwasuneventful,
and the patient was released 5 days after the operation.
Histopathologic study of the specimen demonstrated LAM
and endosalpingiosis in the retroperitoneal lymph nodes.
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and normal pulmonary function tests (spirometry,
plethysmography, and diffusion capacity).
Discussion
The LAM is a rare entity of unknown etiology thatoccurs in
women, normally in their reproductive years, and can be
associated with Tuberous Sclerosis (TS). The prevalence of
sporadic LAM is around one per million in the United
Kingdom, France, and the United States [2,3].
The pathogenesis of the disease is still unknown. It has
been observed that about 25% of the patients who
underwent treatment for LAM previously had oral contra-
ceptives. However, a national case control study found no
association between oral contraceptive use and LAM [4].
There are very few reported cases of extrapulmonary LAM
without pulmonary affectation, and Kebria identified
21 cases [5].
The coexistence of proliferation of atypical smooth muscle
cells with endosalpingiosis in the retroperitoneal lymph
nodes in patients with LAM is a unusual finding.
Endosalpingiosis is a benign condition characterized by
the presence of glands lined by ciliated tubal-type
epithelium [2].
Prevalence of extrapulmonary LAM with endosalpingiosis
is unknown and there are only three cases reported in the
literature [1,6]. Matsui et al. [1] described two women,
36 and 50-year-old, respectively, without previous pul-
monary symptoms. In both the cases, a cystic mass was
found in the retroperitoneum; the first during a cesarean
and the other one during a study of unspecified
abdominal pain. Fukunaga et al. [6] reported a third case
of extrapulmonary LAM associated with endosalpingiosis
in a 25-year-old woman. This patient did not have any
pulmonary affectation, as the aforementioned case.
Clinical manifestations of extrapulmonary LAM are
usually rare. Abdominal pain is an unusual symptom.
Abdominal imaging by ultrasound may show renal AML
and retroperitoneal adenopathy [3] with cystic degenera-
tion which tends to conglomerate and appear like a
retroperitoneal cystic tumor. However, a differential
diagnosis is necessary for other tumor-like retroperitoneal
lymphangioma.
Treatment of pulmonary LAM is based on hormonal
manipulations to prevent progressive lung destruction. At
present, early therapy with intramuscular or oral medroxy-
progesterone is the most-accepted treatment [7]. More-
over, a symptomatic treatment with a thoracostomy tube
or chemical pleurodesis is recommended for chylous
effusion, while a paracentesis or peritoneovenous shunt is
recommended for chylous ascites. Patients with progres-
sive deterioration of pulmonary function can benefit from
lung transplantation, presenting a forecast similar to
transplant patients of other complications [8]. However,
few options remain in managing the retroperitoneal LAM
with no other location. The lack of diagnostic suspicion in
Figure 1. CT scan of the abdomen showing a retroperitoneal
mass (arrow).
Figure 2. Surgical image after excision of the mass.
(1) Inferior mesenteric vein. (2) Left renal vein.
(3) Duodenum. (4) Abdominal aorta. (5) Inferior
mesenteric artery. (6) Left lower polar vein. (7) Ureter.
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entities make surgical resection as the most commonly
used strategy.
As Matsui et al. described, many of patients with
extrapulmonary LAM develop pulmonary LAM within
1-2 years after diagnosis [9]. Various reports describe a
poor prognosis when lungs are involved, with progression
and death from pulmonary complications within 10 years
of diagnosis [2].
Owing to the uncertain behavior of this entity, the
complete removal of the tumor and adjacent lymph is
recommended to prevent expansion and consequent
clinical compression. The frequency of malignant LAM
cases associated with endosalpingiosis has not yet been
described. Given the rarity of its presentation, the
possibility of malignant degeneration cannot be
disregarded.
An excision of the cystic mass and lymphadenectomy was
performed. During the surgical intervention, it was noted
that the cystic mass was located in the retroperitoneal left
center-lateral region surrounding the aorta, the space
between the vena cava and aorta, and renal pelvis,
adhering to the brink of the lateral lumbar vertebral
bodies and the front edge of the left psoas. Despite the
structures involved, excision was performed to conserve
them and continue with an extensive lymphadenectomy.
In summary any patient diagnosed with retroperitoneal
LAM must be studied and followed up to make an early
diagnosis of a possible pulmonary involvement. This
facilitates the treatment of the patients in the early stages
of the disease, thus improving the prognosis. In addition,
surgery is the only therapeutic option in most of these
cases.
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